Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Medicinas Complementares
Métodos Terapêuticos e Terapias MTCI
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Can J Ophthalmol ; 44(2): 181-4, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19491952

RESUMO

OBJECTIVE: To determine whether 5% diphenhydramine solution has an anesthetic effect when administered topically to rabbit corneas. DESIGN: Experimental study. PARTICIPANTS: Twenty white New Zealand rabbits. METHODS: Twenty rabbits at the University of Arkansas for Medical Sciences received 1 drop of 5% diphenhydramine solution in the left eye and 1 drop of balanced salt solution in the right eye. Corneal sensation was then measured with a Cochet-Bonnet esthesiometer at 30-, 60-, and 90-minute intervals. Rabbits were observed for conjunctival reaction. Follow-up fluorescein and Rose Bengal slit-lamp examinations were then performed to assess toxicity. RESULTS: Diphenhydramine solution at a 5% concentration demonstrated a significant anesthetic effect 30, 60, and 90 minutes after instillation (p < 0.0001, p = 0.0001, p = 0.0164, respectively). Mild conjunctival injection occurred in all diphenhydramine-treated eyes. No toxic effects on the corneal epithelium were observed. CONCLUSIONS: When applied topically to rabbit corneas, 5% diphenhydramine solution has a significant anesthetizing effect compared with salt solution (control eyes). Topical diphenhydramine may be a safe alternative in patients requiring topical anesthesia who have multiple allergies to topical anesthetics. Additional studies are needed to determine a dose-response curve and to further evaluate corneal toxicity prior to use in humans.


Assuntos
Anestesia Local/métodos , Anestésicos Locais/administração & dosagem , Córnea/efeitos dos fármacos , Difenidramina/administração & dosagem , Soluções Oftálmicas/administração & dosagem , Administração Tópica , Anestésicos Locais/toxicidade , Animais , Córnea/fisiologia , Difenidramina/toxicidade , Soluções Oftálmicas/toxicidade , Coelhos
4.
Can J Physiol Pharmacol ; 72(1): 57-62, 1994 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-8012899

RESUMO

Ingestion of the anticonvulsant drug valproic acid and of the angiotensin converting enzyme inhibitor captopril during pregnancy has been associated with abnormal fetal outcome in humans. In contrast, the use of the antiinflammatory drug ibuprofen and the antihistamine diphenhydramine has not been documented to be embryotoxic in humans. We evaluated the rat embryo culture system as a predictive model of teratogenesis, using these four drugs as test agents. Valproic acid, ibuprofen, and diphenhydramine were embryotoxic, inducing concentration-dependent decreases in growth and a significant increase in anomalies. Valproic acid caused an increase in neural tube defects, ibuprofen increased the incidence of abnormal maxillary processes, and diphenhydramine increased the number of embryos with distorted body morphology. These abnormalities were induced at concentrations of valproic acid and diphenhydramine that are used clinically, but ibuprofen only induced toxicity at concentrations greatly exceeding the therapeutic range. Captopril was not embryotoxic up to 5 mM, the highest concentration tested. These results suggest that the rat embryo culture system produces both false positive and false negative data on the teratogenic potential of drugs. Although such an in vitro assay may be suitable to determine the mechanism of teratogenesis, it is not a sensitive indicator of potential human teratogens on its own. These data support the view that in vitro systems can only supplement clinical and epidemiological observations in humans, possibly as a method to determine mechanisms of actions of teratogens.


Assuntos
Embrião de Mamíferos/efeitos dos fármacos , Teratogênicos/toxicidade , Anormalidades Induzidas por Medicamentos/patologia , Animais , Captopril/toxicidade , DNA/metabolismo , Difenidramina/toxicidade , Reações Falso-Negativas , Reações Falso-Positivas , Feminino , Humanos , Ibuprofeno/toxicidade , Defeitos do Tubo Neural/induzido quimicamente , Técnicas de Cultura de Órgãos , Gravidez , Ratos , Ácido Valproico/toxicidade
5.
Farmakol Toksikol ; 50(1): 71-4, 1987.
Artigo em Russo | MEDLINE | ID: mdl-3556555

RESUMO

Toxic and pharmacological properties of promedol, droperidol and dimedrol were studied during burn shock and combined radiation and thermal injury (CRTI). Acute toxicity and analgesic effect of promedol were shown to increase in the given period Droperidol analgesic effect enhanced in burn and CRTI, cataleptic action enhanced only in CRTI. A decrease of antihistaminic activity of dimedrol was more pronounced in CRTI.


Assuntos
Queimaduras/tratamento farmacológico , Difenidramina/farmacologia , Droperidol/farmacologia , Meperidina/análogos & derivados , Promedol/farmacologia , Lesões Experimentais por Radiação/tratamento farmacológico , Choque Traumático/tratamento farmacológico , Animais , Difenidramina/toxicidade , Droperidol/toxicidade , Avaliação Pré-Clínica de Medicamentos , Cobaias , Masculino , Camundongos , Promedol/toxicidade , Ratos , Ratos Endogâmicos , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA